Newsroom

Home About Newsroom
Page Navigation

Press Releases

Press Release

BioAgilytix Celebrates Jessica Bridges Weaver for Scientific Leadership with 2026 TBJ Award

Durham, N.C. — March 24, 2026 — BioAgilytix, a global leader in bioanalytical services, is proud to celebrate its commitment to scientific excellence and leadership…

Find Out More
See all Press Releases

Press Release

BioAgilytix Labs, Inc Receives FDA Breakthrough Device Designation for Anti-AAV Antibody Assay 

Durham, N.C. — February 10, 2026— BioAgilytix Labs, Inc, the global leader in bioanalysis, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for…

Find Out More

Press Release

BioAgilytix Named 2025 Fast 50 Award Recipient by Triangle Business Journal

Durham, N.C. — November 1, 2025— BioAgilytix, the global leader in bioanalysis, has been named a recipient of Triangle Business Journal’s Fast 50 award for…

Find Out More

Press Release

BioAgilytix Accelerates Global Growth with LC/MS Investments Across Three Continents

Durham, NC – [October 20, 2025] — BioAgilytix, the global leader in bioanalysis, has advanced its growth strategy with multi-million-dollar investments in Liquid Chromatography–Mass Spectrometry…

Find Out More

Media Coverage

Media Coverage

BioAgilytix Makes Multi-Million-Dollar Investments in LC/MS Capabilities

Officials at BioAgilytix say the company has advanced its growth strategy with multi-million-dollar investments in liquid chromatography–mass spectrometry (LC/MS) capabilities, including new platforms and expanded…

Find Out More

Media Coverage

The Battle to Make Drugs as Pure and Stable as Possible

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them. Click for…

Find Out More

Media Coverage

Company adds jobs with $20M facility despite canceled incentives

BioAgilytix continues to expand in the region despite having an incentives agreement canceled last year. Click for full article

Find Out More
See all media coverage

Media Kit

About BioAgilytix

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany. For more information, please visit www.bioagilytix.com.

Image Library

Click an image below to download our logo.

Media Contact

Noelle Brawner
Communications Manager
BioAgilytix Labs, LLC
media@bioagilytix.com